Week 24 HBeAg and HBsAg are better predictors of sustained response for Chinese HBeAg positive chronic hepatitis B patients receiving 48 weeks Peginterferon α-2b therapy

被引：0
|
作者：
Yang, Song [1 ]
Xing, Huichun [1 ]
Wang, Qixin [2 ]
Xu, Daozhen [1 ]
Cheng, Jun [1 ]
机构：
[1] Beijing Ditan Hosp, Ctr Hepatol, Beijing, Peoples R China
[2] Merck & Co Inc, Beijing, Peoples R China
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
958
引用
收藏
页码：668A / 668A
页数：1
相关论文
共 50 条
  • [21] INTRAHEPATIC HBSAG REDUCTION AFTER PEGINTERFERON TREATMENT IN HBEAG NEGATIVE AND HBEAG POSITIVE CHRONIC HEPATITIS B IS ASSOCIATED WITH SERUM HBSAG DECLINE
    Arends, P.
    Rijckborst, V.
    Sonneveld, M.
    Hansen, B.
    Janssen, H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S196 - S196
  • [22] Use of on-Treatment HBsAg Level and HBeAg Index Can Early Predict Sustained Virological Response in Chronic Hepatitis B, HBeAg Positive Patients Treated With Peginterferon ALPHA-2A
    Phisalprapa, Pochamana
    Charatchamenwitthaya, Phunchai
    Chainuvati, Siwaporn P.
    Nimanong, Supot
    Pausawasdi, Nonthalee
    Prachayakul, Varaytt
    Pongprasubchai, Supot
    Leelakusolvong, Somchai
    Manatsathit, Satapom
    Kachintorn, Udom
    Tanwandee, Tawesak
    GASTROENTEROLOGY, 2011, 140 (05) : S931 - S931
  • [23] PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE
    Chan, H. L.
    Ahn, S. H.
    Chang, T. -T.
    Peng, C. -Y.
    Wong, D.
    Coffin, C. S.
    Lim, S. G.
    Chen, P. -J.
    Janssen, H. L.
    Marcellin, P.
    Serfaty, L.
    Zeuzem, S.
    Cohen, D.
    Critelli, L.
    Xu, D.
    Cooney, E.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S48 - S48
  • [24] PREDICTION OF HBsAg KINETICS AND HBEAG LOSS DURING ANTIVIRAL THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B
    Kim, Hwi Young
    Jang, Tae Soo
    Lee, Joo Ho
    Lee, Hye Ah
    Kwon, Hee-Dae
    HEPATOLOGY, 2020, 72 : 518A - 518A
  • [25] Extended lamivudine consolidation therapy in HBeAg-positive chronic hepatitis B patients achieved a better sustained HBe response
    Chang, K-C
    Kuo, Y-H
    Chen, C-H
    Wang, J-H
    Hung, C-H
    Tseng, P-L
    Lu, S-N
    Changchien, C-S
    Lee, C-M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A195 - A195
  • [26] EXTENDING THE TREATMENT DURATION OF PEGINTERFERON ALFA-2A THERAPY TO 72 WEEKS INCREASES THE RATE OF HBeAg SEROCONVERSION IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B
    Zhu, Y. -Y.
    Dong, J.
    Chen, Y. -T.
    Chen, J.
    Jiang, J. -J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S331 - S332
  • [27] ON-TREATMENT HBSAG LEVEL AND HBEAG INDEX CAN EARLY PREDICT HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B, HBEAG POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2A
    Phisalprapa, Pochamana
    Charatcharoenwitthaya, Phunchai
    Chainuvati, Siwaporn
    Nimanong, Supot
    Prachayakul, Varayu
    Pausawasdi, Nonthalee
    Pongprasobchai, Supot
    Leelakusolvong, Somchai
    Manatsathit, Sathaporn
    Kachintorn, Udom
    Tanwandee, Tawesak
    HEPATOLOGY, 2010, 52 (04) : 526A - 527A
  • [28] Prediction of response to peginterferon α in HBeAg positive chronic hepatitis B: a model based on 721 patients
    Buster, E. H. C. J.
    Hansen, B. E.
    Lau, G. K. K.
    Piratvisuth, T.
    McCloude, P.
    Button, P.
    Steyerberg, E. W.
    Zeuzem, S.
    Janssen, H. L. A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A67 - A68
  • [29] On-treatment HBsAg level and HBeAg index can early predict HBeAg seroconversion in chronic hepatitis B, HBeAg positive patients treated with peginterferon alpha-2a
    Phisalprapa, P.
    Charatcharoenwitthaya, P.
    Chainuwatti, S.
    Nimanong, S.
    Pausawasdi, N.
    Prachayakul, V.
    Pongprasobchai, S.
    Udompanthurak, S.
    Leelakusolvong, S.
    Manatsathit, S.
    Kachintorn, U.
    Tanwandee, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A94 - A94
  • [30] Efficacy and safety of peginterferon alfa-2a in Chinese patients with HBeAg-positive chronic hepatitis B
    Xu, D. -Z.
    Xie, Y.
    Wei, L.
    Chen, X. Y.
    Wan, M. -B.
    Wang, Y. -M.
    Wang, L.
    Wei, J.
    Gan, J. -H.
    Tian, D. -Y.
    Zhang, S. -L.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S266 - S266
12345